(Q24200766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

Adaptive radiation therapy

24 February 2020

main subject

chemotherapy

0 references

0 references

ovarian carcinosarcoma

1 reference

T S Shylasree

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andrew Bryant

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ram Athavale

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

28 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

CD006246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Optimal debulking surgery followed by paclitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Carcinosarcoma of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Carcinosarcomas (Malignant Mullerian Mixed Tumors) of the Uterus and Ovary: A Genetic Study With Special Reference to Histogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Clinical features and outcomes of uterine and ovarian carcinosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Carcinosarcoma of the ovary-a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006246.PUB2

Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital

21 January 2018

1 reference

12 December 2020

Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy

1 reference

12 December 2020

Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases

1 reference

12 December 2020

Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.

1 reference

12 December 2020

Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT)

1 reference

12 December 2020

Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy

1 reference

12 December 2020

Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience

1 reference

12 December 2020

Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed müllerian tumors). Clinicopathologic study of 82 cases.

1 reference

12 December 2020

Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary

1 reference

12 December 2020

Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

1 reference

12 December 2020

Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Carcinosarcoma of the ovary: a case-control study

1 reference

12 December 2020

Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature

1 reference

12 December 2020

Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin

1 reference

12 December 2020

Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients

1 reference

12 December 2020

Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study

1 reference

12 December 2020

Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas

1 reference

12 December 2020

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

1 reference

12 December 2020

10.1002/14651858.CD006246.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1765828

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1765828

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450567%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

PubMed publication ID

23450567

2 references

Consolidated OpenCitations Corpus – April 2017

1765828